Mosaic ImmunoEngineering Inc. (CPMV)
Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. It offers MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in mice, dogs, and humans. The company was founded in 2020 and is based in Novato, California.
$7.24M
3.00
Novato, CA
Jun 01, 2021
-7.69
$-0.13
0.06
0.06
0.00%
-10.15
-0.10
-1.30
0.00
0.06
-249.60%
13.27%
Similar stocks (1)
Emmaus Life Sciences, Inc.
EMMA
$0.04
0.00%
$0.00
Downtrend
Similar stocks (1)
Emmaus Life Sciences, Inc.
EMMA
$0.04
0.00%
$0.00
Downtrend